COMMUNIQUÉS West-GlobeNewswire

Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary Shares
24/04/2019
LONDON, April 24, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (NASDAQ: MREO), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, today announces that, in connection with [...]
Relievant Announces Publication of SMART Trial 24-Month Results
24/04/2019
Intracept® Procedure Demonstrates Durable Results at 24 Months MINNEAPOLIS, April 24, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for [...]
Precipio Launches Global Expansion Strategy
24/04/2019
Precipio to capitalize on powerful data and expertise to grow business globally NEW HAVEN, Conn., April 24, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) announces the launch of [...]
Removing Obstacles from the Modern Infertility Patient’s Journey
24/04/2019
Results Show Patient Dropout is Low in an Employer-Sponsored High-Touch Program NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- RMA of New York, a Manhattan-based fertility clinic and Progyny, the leading fertility [...]
La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria
24/04/2019
-Designation offers potential for expedited development and review, and highlights the urgent need for additional treatment options for patients suffering from severe malaria- - NDA Planned for LJPC-0118 for Fourth [...]
NewLink Genetics to Host Its First Quarter 2019 Conference Call on May 8, 2019
24/04/2019
AMES, Iowa, April 24, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced it will host its first quarter 2019 conference call and webcast at 4:30 PM ET on Wednesday, May 8, 2019, to [...]
Orchestra BioMed™ Receives FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon (SEB)
24/04/2019
First and only non-coated sirolimus-eluting angioplasty balloon system to show promising clinical results Potential to offer significant advantages for treatment of coronary in-stent restenosis (ISR), a condition that [...]
Results from Clinical Trial Show Progenics’ PyL (18F-DCFPyL) PSMA PET/CT Imaging Agent Changes Management Plans for More Than 87% of Patients
24/04/2019
Data from a Prospectively Designed Independent Trial of 130 Patients showed that PyL upstaged and downstaged disease in 65.5% of patients NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. ( [...]
Shockwave Medical to Report First Quarter 2019 Financial Results on May 8, 2019
24/04/2019
SANTA CLARA, Calif., April 24, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Establishment Labs to Announce First Quarter 2019 Financial Results
24/04/2019
NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Wildflower Featured in CannabisNewsWire Publication Spotlighting Spectacular Growth in Cannabis Market
24/04/2019
NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted [...]
Portola Pharmaceuticals Announces Retirement of Dr. John Curnutte, Executive Vice President and Head of Research and Development
24/04/2019
SOUTH SAN FRANCISCO, Calif., April 24, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Dr. John Curnutte, M.D., Ph.D., Executive Vice President and Head of Research and [...]
QBioMed Research Partner Mannin Research to Attend ARVO 2019 Annual Meeting
24/04/2019
NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc . (OTCQB: QBIO ), a biotechnology acceleration company, announced today its technology partner Mannin Research will be attending ARVO 2019 the Annual Meeting of [...]
Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call & Webcast Scheduled for May 8
24/04/2019
REHOVOT, Israel and BRIDGEWATER, N.J., April 24, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Ceapro Inc. to Present at the ThinkEquity Conference in New York City
24/04/2019
– Presentation with live audio webcast Thursday, May 2, 2019 at 9:00 AM EDT – EDMONTON, Alberta, April 24, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology [...]
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
24/04/2019
LAVAL, Quebec, April 24, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Dynacare Announces Vito Ciciretto as new CEO
24/04/2019
BRAMPTON, Ontario, April 24, 2019 (GLOBE NEWSWIRE) -- Dynacare, a Canadian health and wellness solutions company, has announced that, effective immediately, Vito Ciciretto will assume the role of Chief Executive Officer [...]
Dynacare annonce la nomination de son nouveau PDG, Vito Ciciretto
24/04/2019
BRAMPTON, Ontario, 24 avr. 2019 (GLOBE NEWSWIRE) -- Dynacare, une entreprise canadienne qui offre des solutions en matière de santé et de mieux-être, annonce qu’à compter d’aujourd’hui, Vito Ciciretto assumera les [...]
Psychemedics Test for Fentanyl Detection Cleared by FDA
24/04/2019
Industry’s first and only FDA-cleared Fentanyl screen available now ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader and pioneer in detecting drugs of abuse [...]

Pages